Tesla maintained its Bitcoin position through a turbulent quarter, reporting significant unrealized losses as cryptocurrency markets slumped, even as its core automotive business outperformed expectations.
The $7.6 billion RIA has expanded its internal equity plan to 29 employee-owners, formalizing a decade-long succession strategy that aims to preserve independence as co-founder Barry Ritholtz nears 65.
New Oriental Education & Technology Group (NYSE: EDU) sees its stock momentum bolstered by substantial institutional ownership, which now stands near 49%. Last week's $482 million market cap gain adds to a 22% annual return, highlighting investor faith in the Chinese education giant's post-regulatory overhaul trajectory.
The home and security products leader raises its quarterly payout, offering a 1.9% yield. While cash flow coverage appears solid, analysts note the company's mixed dividend history and point to future earnings growth as a key sustainability factor.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
With institutional investors controlling a commanding 59% stake in Amerant Bancorp Inc. (AMTB), the bank's stock price movements are closely tied to the decisions of major funds. This analysis explores the implications of this concentrated ownership, the potential risks of a 'crowded trade,' and what it means for retail investors.
While speculative stories often captivate the market, Waterstone Financial (NASDAQ:WSBF) stands out with consistent profitability and disciplined leadership—traits gaining attention as investors prioritize fundamentals.
A routine commute in Minneapolis turns into a biometric checkpoint, spotlighting the advanced surveillance tools—from facial recognition apps to vast data networks—now central to federal immigration enforcement. As operations intensify, questions mount over privacy, oversight, and the line between targeted enforcement and dragnet surveillance.
Eagle Materials Inc. (NYSE:EXP) boasts a Return on Equity nearly double the industry average. But as investors cheer the metric, a deeper look reveals a heavy reliance on debt, raising questions about the sustainability of its impressive performance.
While Virco Mfg. Corporation's stock has declined nearly 10% over the past quarter, a deeper look at its financials—particularly its high profit reinvestment and strong earnings growth—suggests underlying strength that the market may be overlooking.
Multiple executives and board members at AmeriServ Financial have been buying shares in the company over the past year, a move often interpreted as a bullish signal for the regional bank's prospects.
Amidst market turbulence, European investors are turning to high-yield dividend stocks for income stability. We examine three companies offering compelling payouts, weighing their potential rewards against inherent risks.
Shares of life sciences toolmaker Qiagen (NYSE:QGEN) have shown renewed momentum, gaining over 12% in the past month. This surge brings the company's valuation into sharp focus, with analysts divided between near-term earnings multiples and long-term cash flow projections.
Multiple company directors at the UK hydrogen power specialist have invested heavily in its stock over the past year, a move often interpreted as a bullish signal on future prospects, despite the shares trading significantly higher now.
Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.
Nomura Holdings (TSE:9716) has surged 33% in three months, briefly pausing last week. As shares hover around ¥1,367, analysts debate whether the market has fully priced in the brokerage's recovery or if a significant valuation gap remains.
Baker Hughes (BKR) is accelerating its pivot beyond traditional oil and gas, securing key roles in a landmark U.S. clean ammonia plant and expanding its stake in long-duration energy storage technology through a deepened partnership with Hydrostor.
Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Northeast Bank's Q2 2026 results reveal a bank in transition: record loan growth and a promising new small business product are countered by rising charge-offs and a token dividend, leaving analysts divided on its investment narrative.
